Table 2.
Grade of arthrosis* |
Lameness-score | SIPVFz | SIIFz |
Pain- score |
NSAID's |
Physio- therapy |
OTE |
---|---|---|---|---|---|---|---|
3 | 1 | 0 | 0 | 1 | 0 | 0 | 2 |
1 | −1 | −1 | −1 | 1 | −1 | 0 | −3 |
2 | 0 | −1 | 0 | 0 | 0 | 0 | −1 |
2 | 1 | - | - | 0 | 0 | 0 | |
1 | 1 | −1 | 1 | 1 | 0 | 0 | 2 |
1 | 0 | 0 | −1 | 1 | 0 | 0 | 0 |
2 | 1 | 1 | 1 | 0 | 0 | 0 | 3 |
3 | 0 | −1 | −1 | 1 | 0 | 0 | −1 |
2 | 0 | 0 | −1 | 1 | 0 | 0 | 0 |
3 | 0 | 0 | −1 | 0 | 0 | 0 | −1 |
1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
1 | - | - | - | - | - | - | |
3 | 1 | 1 | 1 | 0 | 0 | 0 | 3 |
2 | 1 | 1 | 1 | 0 | 0 | 0 | 3 |
The data were compared to their pre-treatment values (M1) and defined as follows: +1, improvement; 0, no change; and −1, worsening. Furthermore, the grade of the arthrosis in the affected joint was added to the table, regarding to the IEWG Scheme. OTE, overall treatment effectiveness; TG, treatment group; PG, placebo group; M, measurement point; SIPVFz, symmetry index of the peak vertical force; SIIFz, symmetry index of the vertical impulse; NSAID, non-steroidal anti-inflammatory drug.
According to the IEWG Scheme (23).